HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of selective iNOS inhibition on gut and liver O2-exchange and energy metabolism during hyperdynamic porcine endotoxemia.

Abstract
We have previously demonstrated that non-selective nitric oxide synthase (NOS) inhibition did not reverse the LPS-induced deterioration of hepato-splanchnic energy status in porcine endotoxic shock. Therefore, this study investigated the effect of selective inducible NOS (iNOS) inhibition using 1400 W on intestinal and liver perfusion, O2 kinetics, and energy metabolism during hyperdynamic porcine endotoxemia. Intravenous E. Coli LPS was continuously infused over 24 h concomitant with fluid resuscitation. After 12 h of endotoxemia, continuous intravenous infusion of 1400 W was started until the end of the experiment and was titrated to maintain mean blood pressure (MAP) at baseline levels. Twelve, 18, and 24 h after starting LPS, we measured hepatic arterial and portal venous blood flow, ileal mucosal-arterial PCO2 gap, portal as well as hepatic venous lactate/pyruvate ratios, and endogenous glucose production rate. Expired NO and plasma nitrate levels were assessed as a measure of NO production. 1400 W decreased LPS-induced increase in expired NO and allowed for the maintenance of MAP without modification of cardiac output. Despite unchanged regional macrocirculation, 1400 W prevented the progressive rise of ileal mucosal-arterial PCO2 gap, significantly improved the LPS-induced impairment of hepato-splanchnic redox state, and blunted the decline in liver lactate clearance. Increased glucose production rate was not influenced. Thus, the selective iNOS inhibition with 1400 W prevented circulatory failure and largely attenuated otherwise progressive LPS-induced deterioration of intestinal and hepatocellular energy metabolism.
AuthorsM Matejovic, P Radermacher, I Tugtekin, A Stehr, M Theisen, J Vogt, U Wachter, F Ploner, M Georgieff, K Träger
JournalShock (Augusta, Ga.) (Shock) Vol. 16 Issue 3 Pg. 203-10 (Sep 2001) ISSN: 1073-2322 [Print] United States
PMID11531022 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amidines
  • Benzylamines
  • Enzyme Inhibitors
  • N-(3-(aminomethyl)benzyl)acetamidine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Oxygen
Topics
  • Amidines (pharmacology)
  • Animals
  • Benzylamines (pharmacology)
  • Digestive System (drug effects, metabolism)
  • Endotoxemia (drug therapy, metabolism, physiopathology)
  • Energy Metabolism (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Female
  • Hemodynamics
  • Intestinal Mucosa (metabolism)
  • Intestines (drug effects)
  • Liver (drug effects, metabolism)
  • Male
  • Nitric Oxide Synthase (antagonists & inhibitors, metabolism)
  • Nitric Oxide Synthase Type II
  • Oxygen (metabolism)
  • Perfusion
  • Swine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: